January 09, 2025 11:24 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Pune woman killed by her colleague in full public view for not paying back his money, no one intervenes | Los Angeles wildfire leaves 5 dead, forces 1 lakh including celebs to flee, Hollywood hills ablazed | PM Modi condoles death of six people in Tirupati stampede incident | Days after condemning Pak airstrikes, India in a first engages with Afghanistan's Taliban regime | 6 dead in stampede near Tirupati temple during token distribution to offer prayers | Prominent journalist-film producer Pritish Nandy dies of cardiac arrest at 73 | Thousands, including Hollywood stars, flee Los Angeles upscale neighbourhood as wildfire engulfs homes | Sheesh Mahal row: AAP leaders who were denied entry into CM's residence turn towards PM's house | Anna University sexual assault accused is a DMK supporter, not member: MK Stalin | Ajit Doval, Raja Dato discuss bilateral cooperation during India-Malaysia Security Dialogue

GlaxoSmithKline Consumer Healthcare records 7.5 % growth for Q1 FY 2016

| | Aug 06, 2015, at 03:41 am
New Delhi, Aug 5 (IBNS): GlaxoSmithKline Consumer Healthcare Limited on Wednesday declared its financial results for the first quarter ended June 30, 2015.
Net sales at Rs 990 crores recorded a growth of 7.5% over 2014 with PAT at Rs. 155 crores growing by 19.1% for the same period and PBT at Rs 238 crores growing by 20.1%.

Commenting on the results,  Manoj Kumar, Managing Director, GlaxoSmithKline Consumer Healthcare Limited said, “The first quarter has begun on a positive note – Horlicks and Boost are among the top three HFD in the country. We continue to stay ahead of the category, increasing our market share and volumes. Our growth is a reflection of distribution expansion, enhanced marketing campaigns as we continue to bring nutrition to suit each lifestyle and support all lifecycle.”

"Our efforts for the future will be to continue to service the unmet needs of the consumers through health enhancing products backed by high science. We will continue to focus on our distribution process so that our products reach more people at price points that are competitive and thereby bringing health to everyone,” Kumar said.
 

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.